Ze-gen, Inc.

Walt Howard Joins Ze-gen As Chief Executive Officer

Walt Howard Joins Ze-gen As Chief Executive Officer

December 8, 2010

 Boston, MA — December 8, 2010 — Ze-gen, Inc., a leading developer and integrator of advanced gasification technology to convert waste streams into synthesis gas, welcomes Walter Howard as Chief Executive Officer, replacing Bill Davis who founded Ze-gen in 2004. An industry veteran, with more than 30 years of global power project development experience, Mr. Howard has held CEO, COO, CFO, and SVP executive positions with utility leaders including General Electric, American Water, US Generating (an affiliate of PG&E and Bechtel), Noble Power Assets, J.Makowski Co.

Receptos, Inc.

Faheem Hasnain Named President and Chief Executive Officer of Receptos

Faheem Hasnain Named President and Chief Executive Officer of Receptos

December 2, 2010

Industry veteran will strengthen Receptos’s clinical and commercial expertise in multiple sclerosis and expand activities including the potential to acquire additional focused therapeutic assets

Quanterix Corporation

Dr. Martin Madaus Joins Quanterix Board of Directors

Dr. Martin Madaus Joins Quanterix Board of Directors

December 1, 2010

CAMBRIDGE, Mass., Dec. 1, 2010 /PRNewswire/ -- Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company's Board as Executive Chairman. Dr.

Joule Unlimited, Inc.

Joule Expands Senior Management Team

Joule Expands Senior Management Team

November 29, 2010

Cambridge, Mass. – November 29, 2010 – Joule Unlimited, Inc., pioneer of Liquid Fuel from the Sun™, today announced the expansion of its senior management team to support the company's rapid progress towards high-volume commercial production of renewable diesel fuel. Eric d'Esparbes has joined as Chief Financial Officer, and Kevin Madden has joined as Vice President of Biology Operations.

Selventa

Genstruct, Inc. Changes Name to Selventa as Company Launches Re-branding Effort

Genstruct, Inc. Changes Name to Selventa as Company Launches Re-branding Effort

November 30, 2010

CAMBRIDGE, Mass. – November 30, 2010 – SelventaTM, which evolved from Genstruct®, Inc. today announced that it has changed its name and launched a re-branded website as part of an initiative to provide innovative solutions for its client partners. The company’s core strengths embrace a customer-focused approach that leverages existing patient data and innovative analytics to help pharmaceutical and biotechnology partners accelerate development and clarify decisions on therapeutics and diagnostics.

BG Medicine, Inc.

BG Medicine Announces FDA 510(k) Clearance of its Galectin-3 Test for Use in Patients with Chronic Heart Failure

BG Medicine Announces FDA 510(k) Clearance of its Galectin-3 Test for Use in Patients with Chronic Heart Failure

November 23, 2010

First FDA-Cleared Test to Measure Protein Implicated in Heart Failure Progression

Black Duck Software, Inc.

Black Duck Software Acquires SpikeSource; Range of Technologies Including Cloud-based Component Identification Will Enhance Black Duck’s Ohloh Initiative

Black Duck Software Acquires SpikeSource; Range of Technologies Including Cloud-based Component Identification Will Enhance Black Duck’s Ohloh Initiative

November 16, 2010

Market-leading Growth Fuels Additional Acquisitions; Supports FOSS Adoption by Expanding Tools and Access to FOSS Projects

AVEO Pharmaceuticals, Inc.

AVEO Reports Third Quarter 2010 Financial Results and Recent Developments

AVEO Reports Third Quarter 2010 Financial Results and Recent Developments

November 4, 2010

Current Financial Position Supports Expanding and Accelerating Clinical Development Plans for Tivozanib

[Note: To view this press release in it's entirety, including the Third Quarter Results in detail, click here.]

Helicos BioSciences Corporation

Helicos BioSciences Amends Patent Infringement Lawsuit Against Pacific Biosciences to Include Illumina and Life Technologies

Helicos BioSciences Amends Patent Infringement Lawsuit Against Pacific Biosciences to Include Illumina and Life Technologies

October 25, 2010

CAMBRIDGE, Mass., Oct 25, 2010 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has amended its lawsuit against Pacific Biosciences of California, Inc. for patent infringement by naming Illumina, Inc. and Life Technologies Corporation as additional defendants. The amended lawsuit, Helicos BioSciences Corporation v. Pacific Biosciences of California, Inc., Life Technologies Corporation, and Illumina, Inc., No.

Joule Unlimited, Inc.

U.S. Senator John Kerry Visits Joule, Calls Renewable Fuel Platform "Game Changing"

U.S. Senator John Kerry Visits Joule, Calls Renewable Fuel Platform "Game Changing"

October 14, 2010

Cambridge, Mass. – October 14, 2010 – U.S. Senator John Kerry today visited the office and laboratories of Joule Unlimited, Inc., calling its technology platform potentially "game changing" in the all-important race to replace fossil fuels. The Senator met with members of Joule's executive team and toured the site for a first-hand look at Joule's advances in biology and integrated system design, which together form a platform for renewable fuel production that will eclipse the scale, efficiencies and net energy yield of any known alternative to fossil fuels today.